•  
  •  
  •  
  •  

2025-08-31 16:18:37

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Titan unveils 8 new brand outlets across Delhi NCR, strengthening their retail footprint with 1000+ stores in FY26
  • Zigly Unveils New Experience Centre at Phoenix Marketcity, Strengthens Mumbai Presence
  • XTGlobal Infotech Ltd and ICICI Bank Ltd enter into loan agreement
  • NCC Limited receives orders worth Rs. 788.34 crore
  • Thomas Cook India & SOTC Travel ink long-term strategic MOU with Queensland Tourism

Keywords Selected:  IOLChemicalsandPharmaceuticals

Stock Report

  • IOL Chemicals and Pharmaceuticals Ltd posts Rs. 33.93 crores consolidated profit in Q1 FY26
  • IOL Chemicals and Pharmaceuticals Ltd registers Acetic Anhydride with REACH
  • IOL awarded EcoVadis Silver Medal - Ranks Among the Top 15% companies globally
  • IOL Chemicals and Pharmaceuticals Ltd consolidated Q4 FY2025 net profit higher at Rs. 31.42 crores
  • IOL Chemicals and Pharmaceuticals Ltd receives approval CDE of NMPA, China for Ibuprofen
  • EDQM issues CEP Certificate for IOL Chemicals and Pharmaceuticals Ltd's API Quetiapine Fumarate
  • EDQM issued CEP Certificate for MESALAZINE
  • IOL Chemicals and Pharmaceuticals Ltd board approves 5 For 1 Stock Split
  • Indian Chemical Council awarded Responsible CareĀ® Logo to IOL Chemicals and Pharmaceuticals Ltd
  • EDQM issues CEP certificate to IOL Chemicals and Pharmaceuticals Ltd for Valsartan
  • NMPA, China approves Fenofibrate manufactured by IOL Chemicals and Pharmaceuticals Ltd
  • IOL Chemicals and Pharmaceuticals Ltd receives EDQM CEP certificate for Allopurinol
  • IOL Chemicals and Pharmaceuticals Ltd receives EDQM CEP certificate for Pantoprazole Sodium Sesquihydrate
  • IOL Chemicals and Pharmaceuticals Ltd consolidated Q4 FY2023-24 net profit at Rs. 27.62 crores
  • IOL Chemicals and Pharmaceuticals Ltd receives GMP Certificate issued by Brazilian Health Regulatory Agency ANVISA
  • IOL Chemicals and Pharmaceuticals Ltd successfully completes ANVISA GMP audit
  • IOL Chemicals and Pharmaceuticals Ltd's product approved by CDE of NMPA, China
  • IOL Chemicals and Pharmaceuticals Ltd Q1 FY24 consolidated PAT drops QoQ to Rs. 45.86 crores
  • IOL Chemicals and Pharmaceuticals Ltd rating reaffirmed to A+ by CARE Ratings
  • IOL Chemicals and Pharmaceuticals Ltd's Acetic Anhydride Plant goes on stream
  • IOL Chemicals and Pharmaceuticals receives CEP for Paracetamol to Export in European Market
  • IOL Chemicals and Pharmaceuticals Ltd Q4FY23 consolidated net profit climbs to Rs. 64.78 crores
  • IOL Chemicals and Pharmaceuticals appoints Vikas Vij as CEO
  • IOL Chemicals and Pharmaceuticals Limited announces board rejig

Latest Post

  • Titan unveils 8 new brand outlets across Delhi NCR, strengthening their retail footprint with 1000+ stores in FY26
  • Zigly Unveils New Experience Centre at Phoenix Marketcity, Strengthens Mumbai Presence
  • XTGlobal Infotech Ltd and ICICI Bank Ltd enter into loan agreement
  • NCC Limited receives orders worth Rs. 788.34 crore
  • Thomas Cook India & SOTC Travel ink long-term strategic MOU with Queensland Tourism


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024